# RIVASTIGMINE
> **ANDA215445** · Abbreviated New Drug Application (Generic) · Sponsor: YICHANG HUMANWELL · Approved 2025-09-23
## Drug
- **FDA Application Number:** ANDA215445
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIVASTIGMINE
- **Generic name:** Rivastigmine
- **Active ingredients:** RIVASTIGMINE
- **Dosage form:** FILM, EXTENDED RELEASE
- **Route:** TRANSDERMAL
- **Marketing status:** Prescription
- **Sponsor:** YICHANG HUMANWELL
- **First approval:** 2025-09-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215445)
---
*AI Analytics · CC0 1.0*